Proctitis: Difference between revisions

(Add Doxycycline AntibioticDose entries)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
<languages/>
==Background==
==Background==
===Causes===
===Causes===
*Radiation treatment
*Radiation treatment
*Autoimmune
*Autoimmune
*Vasculitis
*Vasculitis
*Ischemia
*Ischemia
*Infectious ([[STI]] and enteric organisms)
*Infectious ([[STI|STI]] and enteric organisms)
 


==Clinical Features==
==Clinical Features==
===General===
===General===
*Inflammation of the rectal mucosa
*Inflammation of the rectal mucosa
*Pain on defecation
*Pain on defecation
Line 14: Line 24:
*Mucoid discharge
*Mucoid discharge
*Inguinal lymphadenopathy (may be seen with [[Syphilis|T. pallidum]])
*Inguinal lymphadenopathy (may be seen with [[Syphilis|T. pallidum]])


===By Causative Agent===
===By Causative Agent===
*[[Condyloma Acuminata]]
 
*[[Gonorrhea]]
*[[Condyloma Acuminata|Condyloma Acuminata]]
*[[Gonorrhea|Gonorrhea]]
**Symptoms vary from none to severe rectal pain with yellow, bloody discharge
**Symptoms vary from none to severe rectal pain with yellow, bloody discharge
**Unlike nonvenereal cryptitis, infection is not confined to the posterior crypt
**Unlike nonvenereal cryptitis, infection is not confined to the posterior crypt
*[[Chlamydia]]
*[[Chlamydia|Chlamydia]]
**Infection due to direct anorectal infection or via vaginal seeding to perirectal lymphatics
**Infection due to direct anorectal infection or via vaginal seeding to perirectal lymphatics
**Symptoms range from asymptomatic to anal pruritus, pain, purulent discharge
**Symptoms range from asymptomatic to anal pruritus, pain, purulent discharge
**Lymphogranulomatous variety
**Lymphogranulomatous variety
***Acutely painful anal ulcerations associated with unilateral lymph node enlargement
***Acutely painful anal ulcerations associated with unilateral lymph node enlargement
***[[Fever]] and flulike symptoms
***[[Fever|Fever]] and flulike symptoms
***May result in rectal scarring, stricturing, perirectal abscesses, chronic fistulas
***May result in rectal scarring, stricturing, perirectal abscesses, chronic fistulas
*[[Syphilis]]
*[[Syphilis|Syphilis]]
**Primary
**Primary
***Anal chancres appear ~2-6 weeks after intercourse, are often painful
***Anal chancres appear ~2-6 weeks after intercourse, are often painful
Line 35: Line 47:
**Secondary
**Secondary
***Condylomata lata (flatter and firmer than condylomata acuminata)
***Condylomata lata (flatter and firmer than condylomata acuminata)
*[[Herpes Simplex Virus-2]]
*[[Herpes Simplex Virus-2|Herpes Simplex Virus-2]]
**Itching and soreness in perianal area progressing to severe anorectal pain
**Itching and soreness in perianal area progressing to severe anorectal pain
***Accompanied by flulike illness, inguinal adenopathy
***Accompanied by flulike illness, inguinal adenopathy
**Early lesions are small, discrete vesicles on erythematous base
**Early lesions are small, discrete vesicles on erythematous base
***Vesicles then enlarge, coalesce, and rupture, forming exquisitely tender ulcers
***Vesicles then enlarge, coalesce, and rupture, forming exquisitely tender ulcers


==Differential Diagnosis==
==Differential Diagnosis==
{{Anorectal DDX}}
{{Anorectal DDX}}


==Evaluation==
==Evaluation==
*Consider Gram stain and culture
*Consider Gram stain and culture


==Management==
==Management==
{{Presumed GC chlamydia of cervix, urethra, or rectum}}
{{Presumed GC chlamydia of cervix, urethra, or rectum}}


===[[Syphilis]]===
*[[Penicillin]] G 2.4mil IM x1


===[[Herpes Simplex Virus-2]]===
*[[Acyclovir]] 400mg PO TID x10d for initial episode; 800mg TID x2d for recurrent episodes


===[[Lymphogranuloma Venereum]]===
===[[Syphilis|Syphilis]]===
 
*[[Penicillin|Penicillin]] G 2.4mil IM x1
 
 
===[[Herpes Simplex Virus-2|Herpes Simplex Virus-2]]===
 
*[[Acyclovir|Acyclovir]] 400mg PO TID x10d for initial episode; 800mg TID x2d for recurrent episodes
 
 
===[[Lymphogranuloma Venereum|Lymphogranuloma Venereum]]===
 
*Consider in patients with bloody discharge, perianal or mucosal ulcers, chlamydia NAAT+, and MSM
*Consider in patients with bloody discharge, perianal or mucosal ulcers, chlamydia NAAT+, and MSM
*Extend [[doxycycline]] 100mg PO BID for 21 days total<ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1</ref>
*Extend [[doxycycline|doxycycline]] 100mg PO BID for 21 days total<ref>Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1</ref>
 
 
 
===Antibiotic Dosing===
====Adult====
*{{AntibioticDose|drug=Doxycycline|dose=100mg PO q12h x 7 days|context=Proctitis|disease=Proctitis|population=Adult}}
====Pediatric====
*{{AntibioticDose|drug=Doxycycline|dose=Adolescents; 100mg PO q12h x 7 days|context=Proctitis|disease=Proctitis|population=Pediatric}}


==Disposition==
==Disposition==


==See Also==
==See Also==
*[[Anorectal Disorders]]
 
*[[Anorectal Disorders|Anorectal Disorders]]
 


==External Links==
==External Links==


==References==
==References==
<references/>
<references/>
[[Category:GI]]
[[Category:GI]]

Latest revision as of 11:00, 20 March 2026


Background

Causes

  • Radiation treatment
  • Autoimmune
  • Vasculitis
  • Ischemia
  • Infectious (STI and enteric organisms)


Clinical Features

General

  • Inflammation of the rectal mucosa
  • Pain on defecation
  • Tenesmus
  • Mucoid discharge
  • Inguinal lymphadenopathy (may be seen with T. pallidum)


By Causative Agent

  • Condyloma Acuminata
  • Gonorrhea
    • Symptoms vary from none to severe rectal pain with yellow, bloody discharge
    • Unlike nonvenereal cryptitis, infection is not confined to the posterior crypt
  • Chlamydia
    • Infection due to direct anorectal infection or via vaginal seeding to perirectal lymphatics
    • Symptoms range from asymptomatic to anal pruritus, pain, purulent discharge
    • Lymphogranulomatous variety
      • Acutely painful anal ulcerations associated with unilateral lymph node enlargement
      • Fever and flulike symptoms
      • May result in rectal scarring, stricturing, perirectal abscesses, chronic fistulas
  • Syphilis
    • Primary
      • Anal chancres appear ~2-6 weeks after intercourse, are often painful
        • May be misdiagnosed as simple fissure
          • Symmetric lesion on opposite side of anal margin is distinguishing feature
          • Inguinal adenopathy is often present
    • Secondary
      • Condylomata lata (flatter and firmer than condylomata acuminata)
  • Herpes Simplex Virus-2
    • Itching and soreness in perianal area progressing to severe anorectal pain
      • Accompanied by flulike illness, inguinal adenopathy
    • Early lesions are small, discrete vesicles on erythematous base
      • Vesicles then enlarge, coalesce, and rupture, forming exquisitely tender ulcers


Differential Diagnosis

Anorectal Disorders


Non-GI Look-a-Likes


Evaluation

  • Consider Gram stain and culture


Management

Presumed GC/chlamydia of cervix, urethra, or rectum (uncomplicated)[1]

Typically, treatment for both gonorrhea and chlamydia is indicated, if one entity is suspected.

Standard


Ceftriaxone contraindicated

^Additional chlamydia coverage only needed if treated with cefixime only

Partner Treatment


Syphilis


Herpes Simplex Virus-2

  • Acyclovir 400mg PO TID x10d for initial episode; 800mg TID x2d for recurrent episodes


Lymphogranuloma Venereum

  • Consider in patients with bloody discharge, perianal or mucosal ulcers, chlamydia NAAT+, and MSM
  • Extend doxycycline 100mg PO BID for 21 days total[2]


Antibiotic Dosing

Adult

Pediatric

Disposition

See Also


External Links

References

  1. Cyr SS et al. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916
  2. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1